Current through December 10, 2024
Rule 24-2-53.7 - Diversion ControlA. The program must develop, implement, maintain, and document implementation of a written plan to reduce the possibilities for diversion of controlled substances from legitimate treatment to illicit use. The diversion control plan must include, at a minimum, policies and procedures for:1. Continuous monitoring of clinical and administrative activities related to dosing and take-home dispensing practices to identify weaknesses and reduce the risk of medication diversion;2. Problem identification and correction, including for prevention of related diversion problems;3. Specific assignment of diversion control measures to employees who are identified in the diversion control plan to demonstrate accountability to patients and the community;4. Random and unannounced drug screening for all employees, including full-time or contract employees;5. Video-camera surveillance in medication area(s), both within the dispensing area and outside the dispensing area with all monitoring conducted by the administrator and/or security personnel;6. Surveillance in the parking lot of the clinic and surrounding areas, including security camera(s) with outdoor monitoring capabilities;7. Loitering by people being served around the building and surrounding area(s) is not permitted;8. Procedures for people who are dispensed three (3) or more take-home doses are to receive a minimum of two (2) call-backs annually;9. Restriction of employees from taking purses or bags into the medication area(s); and10. Only one (1) person at a time at the medication window.B. The OTPs must have written procedures utilized for handling biohazardous medical waste material, which provide at a minimum the following: